Global Therapeutic Drug Monitoring Market Is Projected to Grow at a CAGR of 7.4% to 2020

Dublin, March 31, 2016 -- Research and Markets has announced the addition of the "Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital, Private Labs) - Global Forecast to 20200" report to their offering.

Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.).

Technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the market. Adjunct technologies such as biomarker identification using proteomics to accurately identify clinical outcomes and genetic testing are expected to benefit the growth of the therapeutic drug monitoring market. However, high infrastructure costs and dearth of skilled resources may restraint the market growth.

The therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region. On the basis of product, the market is segmented into consumables and equipment. The equipment market is further segmented into immunoassay analyzers, proteomic equipment, and other equipment. The consumables segment is expected to account for nearly two-thirds of the global market. The immunoassay analyzers segment is expected to be the fastest-growing segment in its equipment market. Comparatively low costs of immunoassay analyzers and their ease of use are the primary factors driving the market growth in this segment.

On the basis of technology, the therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies and others. The immunoassays segment is expected to account for the largest share of its technology market in 2015. Factors such as relatively simple tests and requirement of minimal training to handle the immunoassay analyzers will drive the growth of this segment.

On the basis of class of drug, the therapeutic drug monitoring market is segmented into antiepileptics, antibiotics, immunosuppressants, antiarrhythmic drugs, bronchodilators, psychoactive drugs, and others classes. The antiepileptics segment is estimated to account for the largest share in 2015. By end user, the market is divided into hospital labs, commercial/private labs, and other end users. The hospital labs segment is estimated to account for the largest share in 2015.

North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutics drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure. The market in Europe on the other hand is growing at a slower rate as the healthcare sector is recovering from the economic downturn and the healthcare facilities are trying to minimize healthcare delivery costs. Growth in the APAC therapeutic drug monitoring market is comparatively slower due to the dearth of skilled healthcare personnel for performing therapeutic drug monitoring tests with minimal errors.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Therapeutic Drug Monitoring Market, By Product

7 Therapeutic Drug Monitoring Market, By Technology

8 Therapeutic Drug Monitoring Market, By Class of Drug

9 Therapeutic Drug Monitoring Market, By End User

10 Global Therapeutic Drug Monitoring Market, By Region

11 Competitive Landscape

12 Company Profiles

- Abbott Laboratories
- Agilent Technologies
- Alere Inc.
- Bio-Rad Laboratories, Inc.
- Biomérieux
- Danaher Corporation
- Roche Diagnostics
- Sekisui Medical Co. Ltd.
- Siemens Healthcare
- Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/3lvmzs/therapeutic_drug

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Pharmaceuticals